DRD2 and obesity due to melanocortin 4 receptor deficiency: In 2001, a study published in The Lancet revealed that individuals with obesity exhibited reduced D2 dopamine receptor availability compared to their eutrophic counterparts, findings that paralleled those observed in substance addiction (Wang et al., 2001).